Disseminated Nontuberculous Mycobacterium Infection During Treatment of Multiple Myeloma: A Case Report and Review of the Literature
Takatoshi Kitazawa, Ai Yamamoto, Shin Nakayama, Kyotaro Kawase, Yoshitaka Wakabayashi
Internal Medicine · 2024-09
Abstract
Multiple myeloma (MM) is a plasma B-cell malignancy characterized by immune dysfunction, with infection representing a major complication. Bacteria, including Streptococcus pneumoniae, are common pathogens in patients with MM, but reports on infections with nontuberculous mycobacteria (NTM) have been limited. We herein report a case of disseminated NTM infection in a patient with MM undergoing treatment with immunomodulatory drugs. At the diagnosis, the patient showed lymphocytopenia and was treated with clarithromycin, rifampicin, and ethambutol; however, culture positivity persisted, and the patient died. The possibility of NTM infection should be considered in cases of unexplained deterioration of the MM patient's general condition.
MeSH terms
- Medicine
- Ethambutol
- Clarithromycin
- Lymphocytopenia
- Nontuberculous mycobacteria
- Multiple myeloma
- Rifabutin
- Streptococcus pneumoniae
- Malignancy
- Rifampicin
- Immunology
- Tuberculosis
- Dermatology
- Internal medicine
- Surgery